Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity

Pasero, Christine, Gravis, Gwenaëlle, Guerin, Mathilde, Granjeaud, Samuel, Thomassin-Piana, Jeanne, Rocchi, Palma, Paciencia-Gros, Maria, Poizat, Flora, Bentobji, Mélanie, Azario-Cheillan, Francine, Walz, Jochen, Salem, Naji, Brunelle, Serge, Moretta, Alessandro, Olive, Daniel · 2016 · Cancer Research

Published version of a preprint

Abstract

The field of immunotherapy for solid tumors, such as prostate cancer, has been recently focusing on therapies that can counter tumor-mediated immunosuppression. Precise quantification and characterization of the immune infiltrates in tumors is crucial to improve treatment efficacy. Natural killer (NK) cells, major components of the antitumor immune system, have never been isolated from prostate tumors, despite their suspected role in disease progression. Here, we examined the frequency, phenotype, and functions of NK cells infiltrating control and tumor prostate tissues. NK cell infiltrates in prostate tissues were mainly CD56 (NCAM1)-positive and displayed an unexpected immature, but activated, phenotype with low or no cytotoxic potential. Furthermore, we show that TGFβ1 (TGFB1) is highly secreted into the prostate environment and partly mediates the immunosuppressive effects on NK cells. In addition to this basal level of immunotolerance to NK cells, the prostate environment became further resistant to NK cell-mediated immunity upon cancer cell infiltration. Coculture experiments revealed that prostate cancer cells induced the expression of inhibitory receptor (ILT2/LILRB1) and downregulated the expression of activating receptors NKp46 (NCR1), NKG2D (KLRK1), and CD16 (FCGR3) by NK cells, thus preventing their recognition of tumor cells. Notably, blood levels of NKp46 were also decreased in prostate cancer patients and were inversely correlated with levels of prostate-specific antigen, the main prognostic factor in prostate cancer. Our study shows that a strong immunosuppressive environment impairs NK cell function at multiple levels in prostate cancer and provides a rationale for the design of therapies that restore NK cell efficiency in the prostate tumor microenvironment. Cancer Res; 76(8); 2153-65. ©2016 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-15-1965

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 48 references

Research works printed but not linked: 1

  1. Reis, 2011, Tgf-beta1 expression as a biomarker of poor prognosis in prostate cancer., Clinics, 66, 1143

Cited by

See all 225

Metadata

Authors
Pasero, C., Gravis, G., Guerin, M., Granjeaud, S., Thomassin-Piana, J., Rocchi, P., Paciencia-Gros, M., Poizat, F., Bentobji, M., Azario-Cheillan, F., Walz, J., Salem, N., Brunelle, S., Moretta, A., & Olive, D.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • 2Institut Paoli-Calmettes, Marseille, France.
  • Institut Paoli-Calmettes (FR)
  • University of Genoa (IT)
Venue
Cancer Research
Published
2016-04-14
Volume
76
Issue
8
Pages
2153-2165
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2329107713
Cited by
209
References
48
Citations by year
2026: 8 · 2025: 23 · 2024: 18 · 2023: 28 · 2022: 25 · 2021: 29 · 2020: 32 · 2019: 12 · 2018: 18 · 2017: 11 · 2016: 5
FWCI
9.28
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
natural killer cells, prostate cancer, tumor microenvironment, immunosuppression, TGF-β1, NK cell inhibitory receptors, NKp46, NKG2D, CD16, CD56, tumor-infiltrating immune cells, prostate-specific antigen, NK cell cytotoxicity
MeSH terms
Cytotoxicity, Immunologic, Humans, Immune Tolerance, Killer Cells, Natural, Male, Neoplasm Metastasis, Prospective Studies, Prostatic Neoplasms, Cytokines, Cell Line, Tumor, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity. https://app.cochat.ai/papers/10.1158/0008-5472.can-15-1965
The paper
Pasero, C., Gravis, G., Guerin, M., Granjeaud, S., Thomassin-Piana, J., Rocchi, P., Paciencia-Gros, M., Poizat, F., Bentobji, M., Azario-Cheillan, F., Walz, J., Salem, N., Brunelle, S., Moretta, A., & Olive, D. (2016). Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity. Cancer Research. https://doi.org/10.1158/0008-5472.can-15-1965

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.